Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
l�ll RhoA, a possible target for treatment of airway hyperresponsiveness in bronchial asthma Chiba Y; Matsusue K; Misawa MJ Pharmacol Sci 2010[]; 114 (3): 239-47Airway hyperresponsiveness to nonspecific stimuli is one of the characteristic features of allergic bronchial asthma. An elevated contractility of bronchial smooth muscle has been considered as one of the causes of the airway hyperresponsiveness. The contraction of smooth muscles including airway smooth muscles is mediated by both Ca(2)+-dependent and Ca(2)+-independent pathways. The latter Ca(2)+-independent pathway, termed Ca(2)+ sensitization, is mainly regulated by a monomeric GTP-binding protein, RhoA, and its downstream target Rho-kinase. In animal models of allergic bronchial asthma, an augmented agonist-induced, RhoA-mediated contraction of bronchial smooth muscle has been suggested. The RhoA/Rho-kinase signaling is now proposed as a novel target for the treatment of airway hyperresponsiveness in asthma. Herein, we will discuss the mechanism of development of bronchial smooth muscle hyperresponsiveness, one of the causes of the airway hyperresponsiveness, based on the recent studies using animal models of allergic bronchial asthma and/or cultured airway smooth muscle cells. The possibility of RhoA as a therapeutic target in asthma, especially airway hyperresponsiveness, will also be described.|Animals[MESH]|Asthma/*drug therapy/*metabolism[MESH]|Bronchi/*physiopathology[MESH]|Bronchial Hyperreactivity/*drug therapy/etiology/metabolism[MESH]|Calcium/metabolism[MESH]|Humans[MESH]|Mice[MESH]|Molecular Targeted Therapy[MESH]|Muscle Contraction[MESH]|Muscle, Smooth/*physiopathology[MESH]|Rats[MESH]|Respiratory System/metabolism/physiopathology[MESH]|Signal Transduction[MESH]|Transcriptional Activation[MESH]|Up-Regulation[MESH]|rho-Associated Kinases/genetics/metabolism[MESH]|rhoA GTP-Binding Protein/genetics/*metabolism[MESH] |